Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/80788

Registo completo
Campo DCValorIdioma
dc.contributor.authorAlmeida-Nunes, Diana Luísapor
dc.contributor.authorFrias, Ana Isabel Mendespor
dc.contributor.authorSilvestre, Ricardo Jorge Lealpor
dc.contributor.authorDinis-Oliveira, Ricardo Jorgepor
dc.contributor.authorRicardo, Sarapor
dc.date.accessioned2022-11-22T16:29:59Z-
dc.date.available2022-11-22T16:29:59Z-
dc.date.issued2022-09-14-
dc.identifier.citationAlmeida-Nunes, D.L.; Mendes-Frias, A.; Silvestre, R.; Dinis-Oliveira, R.J.; Ricardo, S. Immune Tumor Microenvironment in Ovarian Cancer Ascites. Int. J. Mol. Sci. 2022, 23, 10692. https://doi.org/ 10.3390/ijms231810692por
dc.identifier.issn1661-6596por
dc.identifier.urihttps://hdl.handle.net/1822/80788-
dc.description.abstractOvarian cancer (OC) has a specific type of metastasis, via transcoelomic, and most of the patients are diagnosed at advanced stages with multiple tumors spread within the peritoneal cavity. The role of Malignant Ascites (MA) is to serve as a transporter of tumor cells from the primary location to the peritoneal wall or to the surface of the peritoneal organs. MA comprise cellular components with tumor and non-tumor cells and acellular components, creating a unique microenvironment capable of modifying the tumor behavior. These microenvironment factors influence tumor cell proliferation, progression, chemoresistance, and immune evasion, suggesting that MA play an active role in OC progression. Tumor cells induce a complex immune suppression that neutralizes antitumor immunity, leading to disease progression and treatment failure, provoking a tumor-promoting environment. In this review, we will focus on the High-Grade Serous Carcinoma (HGSC) microenvironment with special attention to the tumor microenvironment immunology.por
dc.description.sponsorshipThis work was supported by Fundacão para a Ciência e a Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior and European Union through a PhD fellowship (2021.05081.BD) cosponsored by Fundo Social Europeu (FSE) through Programa Operacional Regional Norte (Norte 2020).por
dc.language.isoengpor
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)por
dc.rightsopenAccesspor
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/por
dc.subjectOvarian cancerpor
dc.subjectMalignant ascitespor
dc.subjectTumor microenvironmentpor
dc.subjectImmune cellspor
dc.subjectCytokinespor
dc.subjectHigh-grade serous carcinomapor
dc.titleImmune tumor microenvironment in ovarian cancer ascitespor
dc.typearticlepor
dc.peerreviewedyespor
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/23/18/10692por
oaire.citationStartPage1por
oaire.citationEndPage23por
oaire.citationIssue18por
oaire.citationVolume23por
dc.date.updated2022-09-22T12:03:13Z-
dc.identifier.eissn1422-0067-
dc.identifier.doi10.3390/ijms231810692por
dc.identifier.pmid36142615por
dc.subject.wosScience & Technologypor
sdum.journalInternational Journal of Molecular Sciencespor
oaire.versionVoRpor
dc.identifier.articlenumber10692por
Aparece nas coleções:ICVS - Artigos em revistas internacionais / Papers in international journals

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
ijms-23-10692.pdf1,87 MBAdobe PDFVer/Abrir

Este trabalho está licenciado sob uma Licença Creative Commons Creative Commons

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID